SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹19,906 Cr | ₹17,208 Cr | ₹16,146 Cr | ₹15,706 Cr | ₹17,340 Cr |
What is the latest Total Current Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Total Current Liabilities |
---|---|
Mar2023 | ₹19,906 Cr |
Mar2022 | ₹17,208 Cr |
Mar2021 | ₹16,146 Cr |
Mar2020 | ₹15,706 Cr |
Mar2019 | ₹17,340 Cr |
How is Total Current Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹19,906 Cr | 15.68 | |
Mar2022 | ₹17,208 Cr | 6.58 | |
Mar2021 | ₹16,146 Cr | 2.80 | |
Mar2020 | ₹15,706 Cr | -9.42 | |
Mar2019 | ₹17,340 Cr | - |
Compare Total Current Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹367,020.9 Cr | 0.5% | -5.7% | 55.1% | Stock Analytics | |
CIPLA | ₹114,925.0 Cr | 1.1% | -4.4% | 55.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -0.7% | 9.4% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 0.1% | 1.1% | 28.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,736.0 Cr | 6% | 2.8% | 93.1% | Stock Analytics | |
MANKIND PHARMA | ₹91,490.4 Cr | -4.2% | -4.7% | NA | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | 0.5% |
-5.7% |
55.1% |
SENSEX | 0.2% |
-0.2% |
20.9% |
You may also like the below Video Courses